Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Infection in Developing Countries|March 16, 2013
Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosisMatteo Morandi, Michela Sali, Riccardo Manganelli, et al.Annali Dell'Istituto Superiore Di Sanita|June 23, 2010
Laboratory procedures for the diagnosis of tuberculosis: a survey in ten Italian RegionsMaria Luisa Moro, Simona Nascetti, Filomena Morsillo, et al.Anaerobe|November 12, 2015
Diagnostic testing for Clostridium difficile in Italian microbiological laboratoriesPatrizia Spigaglia, Fabrizio Barbanti, Matteo Morandi, et al.BMC Public Health|May 25, 2011
Epidemiology of tuberculosis in a low-incidence Italian region with high immigration rates: differences between not Italy-born and Italy-born TB casesAnna Odone, Matteo Riccò, Matteo Morandi, et al.International Journal of Molecular Sciences|March 27, 2025
Lymphomonocytic Extracellular Vesicles Influence Fibroblast Proliferation and Collagen Production in Systemic SclerosisGiuseppe Argentino, Bianca Olivieri, Matteo Morandi, et al.Journal of Medical Microbiology|July 31, 2015
Evolution of macrolide resistance in Streptococcus pyogenes over 14 years in an area of central ItalyRaffaela Olivieri, Matteo Morandi, Alessandra Zanchi, et al.Epidemiologia E Prevenzione|June 4, 2015
[Tuberculosis among children and young adults in Emilia-Romagna Region (Northern Italy): surveillance system and integration with socioeconomic data]Matteo Morandi, Chiara Di Girolamo, Nicola Caranci, et al.Journal of Immunoassay & Immunochemistry|October 28, 2015
Evaluation and Optimization of an ELISA Procedure to Quantify Antibodies Against Pneumococcal Polysaccharides Included in the 13-Valent Conjugate VaccineSimone Belmonti, Francesca Lombardi, Matteo Morandi, et al.Plos One|May 30, 2015
Monosodium Urate Crystals Promote Innate Anti-Mycobacterial Immunity and Improve BCG Efficacy as a Vaccine against TuberculosisFrancesco Taus, Marilina B Santucci, Emanuela Greco, et al.Vaccine|June 3, 2014
Homologous prime boosting based on intranasal delivery of non-pathogenic invasive Escherichia coli expressing MPT64, decreases Mycobacterium tuberculosis disseminationMichela Sali, Elisa Dainese, Matteo Morandi, et al.Pageof 2